PARIS, August 8 /PRNewswire/ -- Aureus Pharma a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announced today the release of its AurSCOPE(R) Kinase Knowledge database. Kinases are an extremely important class of therapeutic drug targets and are implicated in a number of diseases including cancer, chronic inflammation, and metabolic disorders.
This new knowledge database has already been licensed by several life science companies including GlaxoSmithKline and other leaders in the bio pharmaceutical industry.
AurSCOPE Kinase contains biological activity data mined from scientific journals and patents. It contains up to date data including all published chemical structure activity relationships concerning kinase-ligand interactions. It is a complementary addition to the Aureus Pharma knowledge management product portfolio focusing on various target classes. Aureus also offers drug target knowledgebases for G-Protein Coupled receptor (GPCR) and ion channels as well as pharmaceutical safety based knowledgebases for ADME/Drug-Drug Interactions and the hERG channel.
“The AurSCOPE Kinase Knowledgebase will be a valuable resource for the pharmaceutical industry,” said Dr. Andre Michel, Aureus Pharma’s CEO. “It offers researchers the functionality to improve and accelerate lead discovery and optimization tasks involved in the drug discovery process”
About Aureus Pharma
Aureus Pharma headquartered in Paris, France is a privately held knowledge management based solutions provider for the life sciences industry. Aureus Pharma accelerates new drug discovery by providing knowledge databases which contain high quality quantitative information for both chemistry and biology. Researchers gain rapid access to knowledge for important drug target classes including GPCR, Ion Channel, Kinase as well as other critical pharmaceutical topics including ADME/Drug-Drug Interactions and the hERG Channel. The information contained in the Aureus Pharma system is of primary importance to aid in lead discovery and optimization as well as to build predictive models. For further information on how Aureus Pharma helps researchers turn data into discovery visit www.aureus-pharma.com
Media Contact: For Aureus Pharma: Mary E. Donlan, Ph.D Director of Marketing & Sales +33-1-40-18-57-59/+33-6-76-19-51-77 mary.donlan@aureus-pharma.com
AUREUS PHARMA
CONTACT: Media Contact: For Aureus Pharma: Mary E. Donlan, Ph.D, Directorof Marketing & Sales, +33-1-40-18-57-59/+33-6-76-19-51-77,mary.donlan@aureus-pharma.com
